5-Bromoindole

CAS No. 10075-50-0

5-Bromoindole( —— )

Catalog No. M20866 CAS No. 10075-50-0

5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    5-Bromoindole
  • Note
    Research use only, not for human use.
  • Brief Description
    5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
  • Description
    5-bromoindole is a potential inhibitor of glycogen synthase kinase 3 (GSK-3)and an important pharmaceutical chemical intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10075-50-0
  • Formula Weight
    196.04
  • Molecular Formula
    C8H6BrN
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:39 mg/mL (198.93 mM)
  • SMILES
    Brc1ccc2[nH]ccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Butler-Fernández KM Ramos Z Francis-Malavé AMet al.Synthesis Anti-Cancer and Anti-Migratory Evaluation of 36-Dibromocarbazole and 5-Bromoindole Derivatives.Molecules. 2019 Jul 24;24(15). pii: E2686.
molnova catalog
related products
  • Bikinin

    Bikinin (Abrasin) is a plant GSK-3/Shaggy-like kinases inhibitor that activates brassinosteroid (BR) signaling downstream of the BR receptor.

  • GS87

    GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells.GS87 potently inhibits growth of AML cells in mice with little effect on normal bone marrow cells. GS87 causes terminal differentiation of AML cells.

  • WAY-352753

    WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.